Financial Synergies Wealth Advisors, Inc. Dynavax Technologies Corp Transaction History
Financial Synergies Wealth Advisors, Inc.
- $742 Billion
- Q2 2024
Shares
1 transactions
Others Institutions Holding DVAX
# of Institutions
266Shares Held
132MCall Options Held
326KPut Options Held
758K-
Black Rock Inc. New York, NY23.2MShares$269 Million0.01% of portfolio
-
State Street Corp Boston, MA10.6MShares$123 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.4MShares$109 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT9.14MShares$106 Million3.75% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA7.99MShares$92.7 Million0.23% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.47B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...